| Age-adjusted odds ratio (95% CI, P) according to the Osteoprotegerin 950 T/C genotypea | ||
---|---|---|---|
Study group | CC | TC | TT |
Prostate cancer against control | 1.00 | 0.60 (0.345–1.032,0.065) | 0.73 (0.418–1.302,0.294) |
Tumor stageb | Â | Â | Â |
   Stage D against Stage A+B+C | 1.00 | 1.72 (0.801–3.698, 0.164) | 2.76 (1.289–5.938, 0.009) |
   Stage C+D against Stage A+B | 1.00 | 1.74 (0.937–3.253, 0.079) | 2.03 (1.078–3.843, 0.028) |
Tumor gradeb | Â | Â | Â |
   High against Low +Intermediate | 1.00 | 1.27 (0.649–2.498, 0.482) | 1.48 (0.750–2.947, 0.256) |